Product Information
CLOZAPINE ODT 25 MG TABLET is a generic product labeled by Teva Pharmaceuticals USA Inc., priced at $1.6579 per EA under NDC 00093541701. Its NADAC has been published 182 times since Aug 17, 2022.
FDA first approved this application on Nov 25, 2015. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
25 mg/1
Manufacturer
Teva Pharmaceuticals USA Inc.NDC
00093541701
Classification
Generic
Dosage Form
TABLET, ORALLY DISINTEGRATING
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
CLOZAPINEApproval Type
Generic (ANDA)
FDA Application
ANDA090308FDA Approved
11/25/2015
TE Code
AB
On Market Since
7/25/2017
Pharmacological Classes
Price Statistics
The NADAC for CLOZAPINE ODT 25 MG TABLET has been published 182 times since Aug 17, 2022, and over the history we have for it it has declined 21.9%. The table below summarizes its recorded NADAC range and movement.
| Current price | $1.6579 per EA |
|---|---|
| All-time high | $2.1217 (Aug 16, 2023) |
| All-time low | $1.5629 (Jan 21, 2026) |
| 52-week high | $1.8687 |
| 52-week low | $1.5629 |
| Median price | $1.9717 |
| Average price | $1.8976 |
| Largest weekly change | -15.3% (Apr 17, 2024) |
| Weeks tracked | 182 |
| Tracking since | Aug 17, 2022 |
Generic Alternatives
The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 85% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Teva Pharmaceuticals USA Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Clozapine market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Atypical Antipsychotic class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of CLOZAPINE ODT 25 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for CLOZAPINE ODT 25 MG TABLET, manufactured by Teva Pharmaceuticals USA Inc., is $1.6579 per EA (NDC 00093541701), effective Sep 30, 2026.
How has the price of CLOZAPINE ODT 25 MG TABLET changed over time?
Over the history we have for it, the NADAC for CLOZAPINE ODT 25 MG TABLET has declined 21.9%. It has been tracked across 182 weekly CMS publications since Aug 17, 2022.
What are the highest and lowest recorded NADAC prices for CLOZAPINE ODT 25 MG TABLET?
Since Aug 17, 2022, the NADAC for CLOZAPINE ODT 25 MG TABLET has ranged from a low of $1.5629 (Jan 21, 2026) to a high of $2.1217 (Aug 16, 2023), with a median of $1.9717 per EA.
Are there cheaper alternatives to CLOZAPINE ODT 25 MG TABLET?
Yes. 3 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, CLOZAPINE 25 MG TABLET, is $0.2424 per EA — about 85% below CLOZAPINE ODT 25 MG TABLET.
Who manufactures CLOZAPINE ODT 25 MG TABLET?
CLOZAPINE ODT 25 MG TABLET (NDC 00093541701) is labeled by Teva Pharmaceuticals USA Inc., and CMS classifies it as a generic product.